These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23203914)

  • 1. Antibody-functionalized porous silicon nanoparticles for vectorization of hydrophobic drugs.
    Secret E; Smith K; Dubljevic V; Moore E; Macardle P; Delalat B; Rogers ML; Johns TG; Durand JO; Cunin F; Voelcker NH
    Adv Healthc Mater; 2013 May; 2(5):718-27. PubMed ID: 23203914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A magnetic mesoporous silica nanoparticle-based drug delivery system for photosensitive cooperative treatment of cancer with a mesopore-capping agent and mesopore-loaded drug.
    Knežević NŽ; Lin VS
    Nanoscale; 2013 Feb; 5(4):1544-51. PubMed ID: 23322330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabrication and characterization of photoluminescent silicon nanoparticles for drug delivery applications.
    Ryu J; Cho B; Woo HG; Cho S; Sohn H
    J Nanosci Nanotechnol; 2013 Jan; 13(1):157-60. PubMed ID: 23646711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species and glutathione dual redox-responsive micelles for selective cytotoxicity of cancer.
    Chiang YT; Yen YW; Lo CL
    Biomaterials; 2015 Aug; 61():150-61. PubMed ID: 26002788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SN-38 loaded polymeric micelles to enhance cancer therapy.
    Gu Q; Xing JZ; Huang M; He C; Chen J
    Nanotechnology; 2012 May; 23(20):205101. PubMed ID: 22543761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold nanocluster-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
    Chen T; Xu S; Zhao T; Zhu L; Wei D; Li Y; Zhang H; Zhao C
    ACS Appl Mater Interfaces; 2012 Nov; 4(11):5766-74. PubMed ID: 23043448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrophilic mesoporous carbon nanoparticles as carriers for sustained release of hydrophobic anti-cancer drugs.
    Gu J; Su S; Li Y; He Q; Shi J
    Chem Commun (Camb); 2011 Feb; 47(7):2101-3. PubMed ID: 21183990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs.
    Lu J; Liong M; Zink JI; Tamanoi F
    Small; 2007 Aug; 3(8):1341-6. PubMed ID: 17566138
    [No Abstract]   [Full Text] [Related]  

  • 9. Engineering porous silicon nanostructures as tunable carriers for mitoxantrone dihydrochloride.
    Tzur-Balter A; Gilert A; Massad-Ivanir N; Segal E
    Acta Biomater; 2013 Apr; 9(4):6208-17. PubMed ID: 23274152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial distribution and antitumor activities after intratumoral injection of fragmented fibers with loaded hydroxycamptothecin.
    Wei J; Luo X; Chen M; Lu J; Li X
    Acta Biomater; 2015 Sep; 23():189-200. PubMed ID: 26013039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-targeting siRNA delivery from porous silicon nanoparticles.
    Wan Y; Apostolou S; Dronov R; Kuss B; Voelcker NH
    Nanomedicine (Lond); 2014 Oct; 9(15):2309-21. PubMed ID: 24593001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors.
    Almeida PV; Shahbazi MA; Mäkilä E; Kaasalainen M; Salonen J; Hirvonen J; Santos HA
    Nanoscale; 2014 Sep; 6(17):10377-87. PubMed ID: 25074521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel non-toxic camptothecin formulation for cancer chemotherapy.
    Berrada M; Serreqi A; Dabbarh F; Owusu A; Gupta A; Lehnert S
    Biomaterials; 2005 May; 26(14):2115-20. PubMed ID: 15576186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery.
    Hu Q; Gu G; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Xia H; Chen H; Jiang X; Gao X; Chen J
    Biomaterials; 2013 Jan; 34(4):1135-45. PubMed ID: 23146434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid-functionalized mesoporous silica nanoparticles for efficient photodynamic therapy of cancer cells.
    Gary-Bobo M; Brevet D; Benkirane-Jessel N; Raehm L; Maillard P; Garcia M; Durand JO
    Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):256-60. PubMed ID: 22959805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SN-38-loaded nanofiber matrices for local control of pediatric solid tumors after subtotal resection surgery.
    Monterrubio C; Pascual-Pasto G; Cano F; Vila-Ubach M; Manzanares A; Schaiquevich P; Tornero JA; Sosnik A; Mora J; Carcaboso AM
    Biomaterials; 2016 Feb; 79():69-78. PubMed ID: 26695118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-targeted bioconjugate based delivery of camptothecin: design, synthesis and in vitro evaluation.
    Paranjpe PV; Chen Y; Kholodovych V; Welsh W; Stein S; Sinko PJ
    J Control Release; 2004 Nov; 100(2):275-92. PubMed ID: 15544875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate Cancer.
    Gigliotti CL; Minelli R; Cavalli R; Occhipinti S; Barrera G; Pizzimenti S; Cappellano G; Boggio E; Conti L; Fantozzi R; Giovarelli M; Trotta F; Dianzani U; Dianzani C
    J Biomed Nanotechnol; 2016 Jan; 12(1):114-27. PubMed ID: 27301177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor activity of verbascoside loaded gold nanoparticles.
    Zhang Y; Liu B; Wu H; Li B; Xu J; Duan L; Jiang C; Zhao X; Yuan Y; Zhang G; Zeng X
    J Biomed Nanotechnol; 2014 Dec; 10(12):3638-46. PubMed ID: 26000377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma: Drug delivery, one and two-photon photodynamic therapy.
    Gary-Bobo M; Mir Y; Rouxel C; Brevet D; Hocine O; Maynadier M; Gallud A; Da Silva A; Mongin O; Blanchard-Desce M; Richeter S; Loock B; Maillard P; Morère A; Garcia M; Raehm L; Durand JO
    Int J Pharm; 2012 Aug; 432(1-2):99-104. PubMed ID: 22569231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.